Biorelevant dissolution testing is becoming increasingly integrated in the development and evaluation of oral medicines since it is essential to deliver robust and reproducible oral drug delivery systems in conditions that more closely match the physiological environment.

Read more about how lipid matrix modified released tablets bear up to biorelevant testing in our March edition of Matrix Matters.